Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-7) supplementation for exercise performance and muscle damage recovery
RBR-3bhkdg2Recruiting
- Sponsor
- Universidade Federal de Ouro Preto
- Start
- Mar 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of angiotensin-(1-7) in exercise-induced muscle damage (EIMD) and myalgia (3 arms), sponsored by Universidade Federal de Ouro Preto. Primary endpoints: Physical performance and Muscle damage repair. Started Mar 2024; status: recruiting.
02
Drugs
angiotensin-(1-7)
03
Conditions
exercise-induced muscle damage (EIMD)myalgia
Beyond the preview
Go deeper on RBR-3bhkdg2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3bhkdg2.